Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded Last action
- Contract number
- SPE2DR26FW29H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,626
Award facts
- Contract value 100% obligated
- $27,625.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $27,625.64 to AmerisourceBergen Drug Corp for HUMIRA (Adalimumab) Pen 40 mg/0.4 mL pharmaceutical supplies. The contract is non-set-aside and competitively awarded on a firm fixed price basis, with an ultimate completion date of December 3, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies critical medications and medical supplies to federal agencies, including the Defense Health Agency and U.S. Coast Guard. The company maintains an extensive portfolio of federal contracts with DLA covering a broad range of pharmaceutical products across multiple therapeutic domains. This HUMIRA delivery order represents a routine procurement under the larger SPE2DX prime vendor contract, which enables flexible fulfillment of pharmaceutical requirements across the military health system. The DLA is currently planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards anticipated in the coming years.
Quick answers
Who was awarded contract SPE2DR26FW29H?
SPE2DR26FW29H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26FW29H worth?
The government has obligated $27,626 on SPE2DR26FW29H.
Is contract SPE2DR26FW29H an order under another contract?
Yes. SPE2DR26FW29H is a delivery order under SPE2DR25D3011, an indefinite delivery contract.
Was contract SPE2DR26FW29H competed?
The extent of competition for SPE2DR26FW29H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award